Decreased levels of G6PD, a rate-limiting enzyme of PPP, have been identified in the putamen of patients with early-stage PD, suggesting suppressed PPP and lowered antioxidant capacity (Dai et al., 2023; Dunn et al., 2014). The gene discussed is G6PD; the disease is Parkinson disease.